We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$320M
AUM Growth
+$14.8M
Cap. Flow
-$7.39M
Cap. Flow %
-2.31%
Top 10 Hldgs %
59.37%
Holding
27
New
1
Increased
20
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
CE icon
Celanese
CE
+$7.54M
2
MCHP icon
Microchip Technology
MCHP
+$4.97M
3
BGC icon
BGC Group
BGC
+$143K
4
RUSHA icon
Rush Enterprises Class A
RUSHA
+$117K
5
SLB icon
SLB Ltd
SLB
+$116K

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$13.1M
2
MCK icon
McKesson
MCK
+$8.12M
3
GLD icon
SPDR Gold Trust
GLD
+$6.66K

Sector Composition

Rank Sector Weight
1 Materials 20.13%
2 Financials 18.09%
3 Technology 13.45%
4 Industrials 13.4%
5 Energy 12.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUSHB icon
26
Rush Enterprises Class B
RUSHB
$5.89B
$499K 0.16%
9,501
– –
UNH icon
27
UnitedHealth
UNH
$387B
– –
-25,045
Closed -$13.1M
1
2

Similar funds

AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM
MW
Marks Wealth Annapolis, Maryland $380M AUM 40.02% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
BP
BWM Planning The Woodlands, Texas $379M AUM 21.72% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return

Muhlenkamp & Co's Q2 2025 Portfolio in Review

As of Q2 2025, Muhlenkamp & Co held 27 positions worth $320M, up 4.9% from $306M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Muhlenkamp & Co's Q2 2025 filing shows 1 new, 20 increased, 2 reduced and 1 closed positions. Its largest new stake was Celanese: 151,208 shares worth $8.37M. The largest sale was UnitedHealth, an estimated $13.1M.

By sector, the portfolio is most concentrated in Materials at 20% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Muhlenkamp & Co's largest Q2 2025 buy was Celanese: 151,208 shares worth $8.37M.
  • Muhlenkamp & Co added most to Microchip Technology in Q2 2025, an estimated $4.97M increase.
  • Muhlenkamp & Co's biggest Q2 2025 reduction was McKesson, cutting an estimated $8.12M.
  • Muhlenkamp & Co fully exited UnitedHealth in Q2 2025, selling an estimated $13.1M.
  • Muhlenkamp & Co's ten largest holdings make up 59% of its $320M portfolio in Q2 2025.
  • Muhlenkamp & Co opened 1 new position and closed 1 in Q2 2025.
  • Muhlenkamp & Co's portfolio value rose 4.9% quarter-over-quarter to $320M.

Based on Muhlenkamp & Co's 13F filing for Q2 2025, filed 24 Jul 2025.